Comparison of Time-Dependent Contralateral Breast Cancer Incidence Requires Comparable Lengths of Follow-Up

Affiliations

Comment

Ke-Da Yu et al. J Clin Oncol. 2019.

. 2019 Jun 10;37(17):1515-1516.

doi: 10.1200/JCO.18.02468. Epub 2019 Apr 29.

¹ Ke-Da Yu, MD, and Zhi-Ming Shao, MD, Fudan University, Shanghai, People's Republic of China.

No abstract available

Comment in

Reply to K.-D. Yu et al.
Ruhstaller T, Regan MM. Ruhstaller T, et al. J Clin Oncol. 2019 Jun 10;37(17):1516-1517. doi: 10.1200/JCO.19.00325. Epub 2019 Apr 29. J Clin Oncol. 2019. PMID: 31034299 No abstract available.

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.
Ruhstaller T, Giobbie-Hurder A, Colleoni M, Jensen MB, Ejlertsen B, de Azambuja E, Neven P, Láng I, Jakobsen EH, Gladieff L, Bonnefoi H, Harvey VJ, Spazzapan S, Tondini C, Del Mastro L, Veyret C, Simoncini E, Gianni L, Rochlitz C, Kralidis E, Zaman K, Jassem J, Piccart-Gebhart M, Di Leo A, Gelber RD, Coates AS, Goldhirsch A, Thürlimann B, Regan MM; members of the BIG 1-98 Collaborative Group and the International Breast Cancer Study Group. Ruhstaller T, et al. J Clin Oncol. 2019 Jan 10;37(2):105-114. doi: 10.1200/JCO.18.00440. Epub 2018 Nov 26. J Clin Oncol. 2019. PMID: 30475668 Free PMC article. Clinical Trial.